Insmed (INSM) Tops Q1 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $93.39 -1.76%
EPS Growth %: +77.7%
Financial Fact:
Operating loss: -37.15M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +77.7%
Financial Fact:
Operating loss: -37.15M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.80), $0.08 better than the analyst estimate of ($0.88). Revenue for the quarter came in at $53.1 million versus the consensus estimate of $53.39 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Infosys Limited (INFY) Reports In-Line Q3 EPS
- American Express (AXP) Tops Q3 EPS by 84c, Misses on Revenue, Raises FY Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
